Your session is about to expire
← Back to Search
Rimegepant for Psoriasis
Study Summary
This trial is testing a new migraine medication to see if it also works for plaque psoriasis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I was diagnosed with cancer within the last 5 years.I have Gilbert's Syndrome or another liver/bile duct condition.I have a history of major depression or anxiety.I am between 18 and 75 years old.I have psoriasis affecting more than 3% of my body and a PASI score over 5.I am not taking medications that affect certain enzymes or proteins.I am a woman who can have children and have a recent negative pregnancy test.I have a history of heart disease, high blood pressure, or diabetes that is not well-controlled.I haven't taken any biologic drugs or monoclonal antibodies recently.I have not taken certain medications recently.I have a condition that weakens my immune system.I am currently taking corticosteroids or immunosuppressive medications.You have been diagnosed with psoriasis by a dermatologist or through a skin biopsy.I am using a reliable method of birth control.You have an autoimmune disorder other than psoriasis.I am currently taking medications like CGRP blockers or certain mood stabilizers.Test results that disqualify you from participating in the screening.I have had gallstones in the past.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA granted clearance to Rimegepant?
"Rimegepant's safety has been partially validated in a Phase 2 trial, so it was given an assessment of 2. Unfortunately, there are no clinical data supporting its efficacy yet."
Are there particular demographics that would be beneficial to include in this clinical investigation?
"The qualifications for this medical trial necessitate that participants have psoriasis and be between the ages of 18-75. However, only 30 individuals will ultimately comprise its sample size."
How many participants are being enrolled for this trial at its maximum capacity?
"Affirmative. The clinicaltrial.gov database specifies that this trial, which was originally shared on January 19th 2021 is actively recruiting participants from a single site and needs 30 people to complete the study."
Are there still openings to participate in this experiment?
"Affirmative. Information available on clinicaltrials.gov clarifies that this research study, initially posted in January 2021, is currently enrolling volunteers for the trial. 30 individuals need to be sourced from a single site."
Is this research unprecedented in its scope?
"Since its initial study in 2019, sponsored by Biohaven Pharmaceuticals, Inc., Rimegepant has been actively researched. This drug received Phase 2 approval following the first trial and now there are 6 ongoing studies spanning 9 countries and 251 cities."
What additional medical experiments have been conducted with Rimegepant?
"Currently, 6 clinical trials dedicated to the study of Rimegepant are in progress with 3 reaching Phase 3. While the primary research site is located in Gilbert Arizona, there are 499 other medical centres conducting related studies."
Does this research endeavor offer enrollment to senior citizens?
"The requisites for enrolment in this clinical trial demand that potential participants are between 18-75 years old."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger